Literature DB >> 10077158

The alpha v beta 6 integrin induces gelatinase B secretion in colon cancer cells.

M Agrez1, X Gu, J Turton, C Meldrum, J Niu, T Antalis, E W Howard.   

Abstract

In human cancers, the co-operative role between cell-adhesion receptors and proteases capable of degrading matrix barriers remains poorly understood. We have previously reported that the epithelium-restricted integrin alpha(v)beta6 becomes highly expressed in colon cancer compared with normal mucosa and that heterologous expression of alpha(v)beta6 in colon cancer cells is associated with enhanced cell growth. Herein, we report that alpha(v)beta6 expression in colon cancer cells leads to a relative increase in secretion of the matrix metalloproteinase gelatinase B over its respective inhibitor and that this secretion parallels the level of cell-surface beta6 expression. The alpha(v)beta6-mediated gelatinase B secretion is associated with increased proteolysis of denatured collagen at the cell surface, and inactivation of gelatinase B in beta6-expressing tumour cells inhibits cell spreading and proliferation within 3-dimensional collagen matrices. Our findings suggest that alpha(v)beta6-mediated gelatinase B secretion is important in the progression of human colon cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10077158     DOI: 10.1002/(sici)1097-0215(19990331)81:1<90::aid-ijc16>3.0.co;2-k

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

1.  alpha5beta1 integrin protects intestinal epithelial cells from apoptosis through a phosphatidylinositol 3-kinase and protein kinase B-dependent pathway.

Authors:  J W Lee; R L Juliano
Journal:  Mol Biol Cell       Date:  2000-06       Impact factor: 4.138

2.  The αvβ6 integrin is transferred intercellularly via exosomes.

Authors:  Carmine Fedele; Amrita Singh; Brad J Zerlanko; Renato V Iozzo; Lucia R Languino
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

3.  Overexpression of matrix metalloproteinase 9 in tumor epithelial cells correlates with colorectal cancer metastasis.

Authors:  David S Zuzga; Ahmara Vivian Gibbons; Peng Li; Wilhelm Johannes Lubbe; Inna Chervoneva; Giovanni Mario Pitari
Journal:  Clin Transl Sci       Date:  2008-09       Impact factor: 4.689

4.  Synchronous primary sigmoid colon cancer and primary thyroid cancer followed by a malignant tumor of the kidney: Case report of multiple primary cancer and review of the literature.

Authors:  Cheng Peng; Zequn Li; Huijie Gao; Xueqing Zou; Xiao Wang; Changkuo Zhou; Jun Niu
Journal:  Oncol Lett       Date:  2018-12-24       Impact factor: 2.967

5.  A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins.

Authors:  S R Elshaw; K Sisley; N Cross; A K Murray; S M MacNeil; M Wagner; C E Nichols; I G Rennie
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

6.  Integrin αvβ6 sustains and promotes tumor invasive growth in colon cancer progression.

Authors:  Guang-Yun Yang; Sen Guo; Cong-Ying Dong; Xian-Qiang Wang; Bing-Yang Hu; Yang-Feng Liu; Yong-Wei Chen; Jun Niu; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

Review 7.  Pathophysiology of fistula formation in Crohn's disease.

Authors:  Michael Scharl; Gerhard Rogler
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

8.  Clinical significance of integrin αvβ6 expression effects on gastric carcinoma invasiveness and progression via cancer-associated fibroblasts.

Authors:  Zhuonan Zhuang; Ruiling Zhou; Xiaozhou Xu; Tian Tian; Yi Liu; Yanfeng Liu; Peilong Lian; Jiayong Wang; Kesen Xu
Journal:  Med Oncol       Date:  2013-05-15       Impact factor: 3.064

9.  Peptide-targeted polyglutamic acid doxorubicin conjugates for the treatment of alpha(v)beta(6)-positive cancers.

Authors:  Huili Guan; Michael J McGuire; Shunzi Li; Kathlynn C Brown
Journal:  Bioconjug Chem       Date:  2008-08-19       Impact factor: 4.774

10.  The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy.

Authors:  Xinjie Lu; Dong Lu; Mike Scully; Vijay Kakkar
Journal:  Perspect Medicin Chem       Date:  2008-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.